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We demonstrate the feasibility of a novel and nonionizing process for bladder imaging in vivo, called photoacoustic
cystography (PAC). Using a photoacoustic imaging system, we have successfully imaged a rat bladder filled with
clinically used Methylene Blue (MB) dye. An image contrast of ∼8 was achieved. Further, spectroscopic PAC con-
firmed the accumulation of MB in the bladder. Using a laser pulse energy of less than 1mJ=cm2 (1=20 of the ANSI
safety limit), a deeply (1:2 cm) positioned bladder in biological tissues was clearly visible in the PA image. Our
results suggest that PAC can potentially provide a nonionizing, relatively cheap, and portable tool for bladder map-
ping. Among our clinical interests, nonionizing PAC with an injection of MB can potentially monitor vesicoureteral
reflux in children. © 2011 Optical Society of America
OCIS codes: 110.0110, 170.0170, 170.5120.
Cystoscopy is a gold standard for bladder imaging, yet
this method provides magnified surface properties only.
X-ray computed tomography has been applied, but it is
ionizing and not sensitive. Contrast-enhanced MRI has
been applied, but it is expensive and bulky [1]. Although
ultrasound (US) imaging is real-time, portable, relatively
cost effective, and safe, conventional US imaging is not
sensitive, especially, for imaging bladder cancers [2].
Photoacoustic tomography (PAT) is a hybrid nonioniz-
ing imaging modality that combines the merits of both
light and US, and provides an approach for mapping
the optical absorption contrast [3]. In PAT, a short pulsed
laser source is used to illuminate the tissue sample, and
the photoacoustic (PA) waves excited by thermoelastic
expansion due to light absorption are then measured to
reconstruct the optical absorption distribution. Because
ultrasonic waves are much less scattered than light in
biological tissues, the relative spatial resolution (the ratio
between depth and axial resolution) is maintained ap-
proximately at 200, while the penetration depth of
PAT is extended to several centimeters by using diffuse
rather than ballistic light. Recently, PAT has been exten-
sively explored in preclinical and clinical studies, includ-
ing primary cancer detection, lymph node staging and
lymphangiography, brain activation, ophthalmology,
and image-guided therapy [4–8]. A clinical ultrasonic
scanner has been adapted to PAT, combining the high
contrast of optical imaging and the high resolution of
US imaging [9–11].
In this Letter, for the first time to our knowledge, we
describe the feasibility of a novel and nonionzing ap-
proach for bladder imaging using PAT, referred to as
photoacoustic cystography (PAC). A healthy rat bladder
filled with Methylene Blue (MB) was photoacoustically
and spectroscopically imaged in vivo without any ioniz-
ing radiation. The imaging depth was also extended
beyond 1 cm with a laser pulse energy of <1mJ=cm2.
When combined with a clinical US scanner, this techni-
que can potentially supply an accurate, safe, cheap,
portable, and real-time imaging capabilities for bladder
imaging.
A volumetric PAT system is shown in Fig. 1(a). The
system setup is detailed in [12]. In brief, the light was
delivered from a tunable optical parametric oscillator la-
ser (Surelite OPO PLUS; Continuum; wavelength tunabil-
ity: 410 to 2500 nm) pumped by a Q-switched Nd:YAG
laser (SLII-10; Continuum) with a 5 ns pulse duration
and a 10Hz pulse repetition rate. A light wavelength of
667 nm was used for most of the experiments, but both
667 and 850 nm wavelengths were used for spectroscopic
bladder identification. Formed by a concave lens, a sphe-
rical conical lens, and an optical condenser, the dark-
field light illumination was coaxially aligned with the
US focus in water. The incident laser pulse energy was
less than 1mJ=cm2, far below the ANSI safety limit of
20mJ=cm2 at this wavelength. Generated PA waves were
detected by a single-element 5MHz US transducer (V308;
Olympus NDT). The spatial resolutions were 144 and
590 μm in the axial and transverse directions, respec-
tively. The scanning speed for one PA image was
∼25 min, with a FOV of 2:5 cm × 2:5 cm in the x–y plane.
No signal was averaged.
Approval of the experimental procedure was obtained
from an institutional animal care and use committee.
Healthy Sprague Dawley rats that weighed ∼250 g were
used in all imaging experiments. First, the rats were given
a mixture of ketamine (85mg=kg body weight) and xyla-
zine (15mg=kg) for anesthesia. After depilation in the
abdominal region, the rats were positioned atop a home-
made holder [Fig. 1(b)]. The distal end of a 22-gauge
catheter was coated with lubricant. After the urinary
meatus was identified, the catheter was gently inserted
until urine was noticed. Then, urine in the bladder was
allowed to void through the catheter. Before injection,
we obtained a control image. After injection of MB (clini-
cally used for mapping sentinel lymph nodes in breast
cancer patients [11]), with a concentration of 30mM
and a dose of 0:2ml via the catheter, we acquired a series
of PA images. We added chicken breast tissue on top of
the rats to increase imaging depth. After all imaging ex-
periments, the rat was sacrificed with an overdose of
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pentobarbital. Then, the skin was removed, and the blad-
ders were visualized to confirm the occupation of MB.
The preinjection control PA image [Fig. 2(a)] was
obtained at a wavelength of 667 nm, where the optical
absorption of MB is peaked, and is shown in the form
of maximum amplitude projection (MAP), which projects
the maximum signal along each A line onto the corre-
sponding x–y plane. Figure 2(f) is a photograph of a
rat taken prior to PA image acquisition and after hair
removal and catheterization. The vasculature in the ab-
dominal area was clearly imaged with high contrast
(1:1 0:6, standard deviation with respect to the back-
ground, based on acoustic amplitude). The bladder was
invisible in the control PA image because urine in the
bladder was optically transparent at the 667 nm wave-
length. The bladder appeared unmistakably in the PA
image acquired after MB injection. Because MB has higher
optical absorption (∼2191 cm−1 at 30mM) than blood
(∼3 cm−1 for an artery with 90% hemoglobin oxygen sa-
turation and ∼5:8 cm−1 for a vein with 70% hemoglobin
oxygen saturation) at the 667 nm wavelength, the bladder
appeared with a much higher contrast (8:1 2:1) than the
surrounding blood vessels [Fig. 2(b)]. Certainly, the PA
signal from the bladder filled with MB was saturated.
The contrast of the bladder with respect to the blood ves-
sel was ∼3:4. After injection of MB, without a proper con-
trol image, the bladder was difficult to distinguish from the
surrounding blood vasculature. However, the MB-filled
bladder could be distinguished from surrounding blood
vasculature by collecting images at two wavelengths
(667 and 850 nm). Because of the different optical absorp-
tion coefficients of MB at these wavelengths, the bladder
could be effectively differentiated from blood vessels by
comparing the two images. At 850nm, where the optical
absorption of MB is much reduced, the PA signals from
within the bladder disappeared [Fig. 2(c)]. This result
proved that MB filled the bladder. The bladder filled with
MB is also clearly mapped in the depth-resolved PAB-scan
image [Fig. 2(e)], cut along the dotted line in Fig. 2(b). The
bladder was positioned ∼2mm below the skin surface.
Again, the bladder was invisible in the control PA B-scan
image [Fig. 2(d)]. The accumulation of MB in the bladder
was visually identified in a photograph of the same rat
with the skin removed after PA imaging [Fig. 2(g)].
To explore PA mapping of deeply (∼12mm) located
bladders filled with MB, we imaged in vivo the abdom-
inal region with chicken breast tissue placed on top of the
rat. Before overlaying, a PA image was obtained to con-
firm the occupation of the bladder by MB. The bladder
filled with MB and surrounding vasculatures are clearly
seen in Fig. 3(a). With overlying chicken tissue, the blad-
der was successfully imaged at a depth of 12mm, with an
image contrast of 1:13 0:25 between the bladder and
background [Fig. 3(b)]. Figures 3(c) and 3(d) show
depth-resolved PA B-scan images without and with addi-
tional chicken tissue, respectively. Note that we used a
laser pulse energy of less than 1mJ=cm2, which was
the maximum from our laser. This value is only 1=20
of the current ANSI safety limit. Kim et al. experimentally
proved that they could image an MB-containing tube at a
depth of 5:2 cm in biological tissues, using a handheld
PA/US probe adapted from a clinical US imaging system
and a laser pulse energy of 3mJ=cm2 [11]. If the laser flu-
ence is increased to the ANSI safety limit (20mJ=cm2),
theoretically, the maximum penetration depth can reach
∼7:4 cm [11].
Fig. 1. (Color online) (a) Photograph of the PAT system.
(b) Photograph of an animal with bladder catheterization.
Fig. 2. (Color online) Nonionizing and noninvasive in vivo PA
bladder (BD) imaging in a rat using MB injection. (a) Control PA
image acquired at 667nm in the form of MAP without MB injec-
tion. (b) PA MAP image acquired at 667 nm after MB injection.
(c) PAMAP image acquired at 850nm after MB injection. (d) PA
B-scan image cut along the dotted line in (a). (e) PA B-scan
image cut along the dotted line in (b). (f) Photograph with hair
removed and catheterization before PA imaging. (g) Photograph
with skin removed after PA imaging: BV, blood vessels; RT,
rectum.
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In discussion, we have shown the feasibility of a new
and safe imaging method for delineating bladders. Con-
ventional imaging techniques suffer from either ionizing
radiation or low sensitivity. We have photoacoustically
and spectrally imaged a rat bladder filled with clinically
used MB dye in vivo. A deeply located bladder (beyond
1 cm) was clearly mapped using only 1=20 of the laser
safety limit. Our clinical interests include monitoring ve-
sicoureteral reflux (VUR), the retrograde flow of urine
from the bladder into the upper urinary tract, in children
using PAC. VUR is commonly diagnosed after patients
(typically children) have a urinary tract infection
[13–15]. By transporting bacteria from the bladder, VUR
causes renal infections such as pyelonephritis. There-
fore, early detection and treatment of VUR are essential.
Two main methods have been used to evaluate VUR:
fluoroscopic voiding cystourethrography (VCUG) and di-
rect radionuclide voiding cystography (DRNC) [14].
Although radiation dose reduction has been achieved
in fluoroscopic VCUG, this method is still ionizing.
Further, despite the smaller radiation dose of DRNC, this
technique suffers from low spatial resolution, and
patients are still exposed to radiation. The pediatric
VUR guidelines panel of the American Urological Asso-
ciation strongly urges the development of techniques
with less radiation exposure [13,15]. Echo-enhanced
urosonography has been applied to monitor VUR,
and it offers the advantages of nonionizing, real-time,
and portable imaging capability [14]. However, echo-
enhanced urosonography is sensitive to high-grade reflux
only [16]. Therefore, US imaging alone cannot be used for
VUR tracking. The nonionizing contrast-enhanced PAC
can be an attractive candidate for VUR tracking and com-
pletely avoid radiation exposure to child subjects. If VUR
exists, injected MBwill flow to kidneys and can be photo-
acoustically monitored. The speckle-free nature of PAC,
unlike US imaging, could further enhance the PA image
contrast [17]. On the other hand, the penetration depth of
PAC could be limited due to strong light scattering com-
pared to US imaging. However, the top and bottom sur-
faces of a pediatric bladder are positioned at depths of
∼1:4 and ∼4:3 cm, respectively, from the abdominal sur-
face, as shown in a transverse US image [18]. These
depths are within the current PA imaging penetration
depth, >5 cm [11]. Once it is combined with a conven-
tional US imaging probe, this technique can be portable,
fast, and relatively cost effective. In the future, we will
investigate PA VUR mapping in a porcine model.
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Fig. 3. (Color online) In vivo deeply penetrating PA imaging.
(a) PA image acquired after MB injection and without additional
chicken tissue. (b) PA image taken after MB injection with
additional chicken tissue. (c) Depth-resolved PA B-scan image
cut along the dotted line in (a). (d) Depth-resolved PA B-scan
image cut along the dotted line in (b): BD, bladder; BV, blood
vessels.
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